The ‘Costs Of Inflammatory bowel disease in the Netherlands’ or COIN-study has been initiated to generate longitudinal cost data in order to assess the impact of anti-TNF therapy on IBD-related costs. Here, TNF is linked to inflammatory bowel disease.